Glow Holdings, Inc. (GLOH) plans a direct, best-efforts public offering of up to 35,000,000 shares of common stock at $0.01 per share, for maximum gross proceeds of $350,000. All shares are newly issued by the company, with no selling securityholders and no escrow or minimum raise requirement.
Glow is pivoting from its former TeleCare healthcare business to develop and commercialize the Wabiam enterprise software and SaaS platform focused on workflow automation, operational analytics and AI-enhanced tools, initially targeting Latin American and other emerging markets. The company currently has no revenue from Wabiam, no cash, a net tangible deficit and its auditor has raised substantial doubt about its ability to continue as a going concern.
There are 40,123,783 common shares outstanding before the offering and 75,123,783 if fully subscribed. Sole director and CEO Daniela Carolina Mujica Chacon will own about 50.0% of post-offering common stock and all 700,000 Special 2024 Series B Preferred shares (1,000 votes each), giving her effective voting control even if the offering is fully sold.
Glow Holdings, Inc. (GLOH) plans a Regulation A Tier 1 offering of 35,000,000 shares of common stock at $0.01 per share, for an aggregate offering price of $350,000, all on behalf of the issuer, with estimated net proceeds of $305,000.
The Nevada-based prepackaged software company reports total assets of $7,500,000, total liabilities of $20,178 and stockholders’ equity of $7,479,822. Recent results show revenue of $458,318 and net income of $117,905, or $0.05 basic and diluted EPS, with 40,123,783 common shares outstanding trading on OTC Markets under GLOH.
Within the past year, Glow issued 38,200,000 unregistered common shares for aggregate consideration of approximately $8,400,000, including $7,500,000 of technology and intellectual property assets and 36,000,000 shares as equity compensation under an executive employment agreement.
Glow Holdings, Inc. filed a Registration Statement on Form 10 to register its common stock under the Exchange Act and become a reporting company.
The filing describes a strategic transition toward enterprise software and a business platform called Wabiam Soluciones Tecnológicas, including a Technology Asset Purchase Agreement dated June 1, 2026 under which the company issued 2,000,000 shares of common stock in a private transaction as consideration for acquired technology assets. The registrant states Wabiam is early-stage, that historical revenue derived from TeleCare Home Health LLC, and that Wabiam commercialization, capitalization, and technical development remain ongoing and uncertain.